Steven D. Cosler Buys 7,000 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director Steven D. Cosler bought 7,000 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The shares were purchased at an average price of $21.22 per share, with a total value of $148,540.00. Following the acquisition, the director now directly owns 17,713 shares in the company, valued at approximately $375,869.86. This trade represents a 65.34 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Guardian Pharmacy Services Price Performance

Shares of GRDN stock traded down $0.26 on Wednesday, hitting $21.30. 105,534 shares of the stock traded hands, compared to its average volume of 153,491. Guardian Pharmacy Services, Inc. has a 1-year low of $14.16 and a 1-year high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. On average, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 0.81 earnings per share for the current year.

Analysts Set New Price Targets

GRDN has been the subject of a number of analyst reports. Raymond James initiated coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They issued an “outperform” rating and a $21.00 price target for the company. Truist Financial upped their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, November 15th. Finally, Stephens assumed coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price target for the company.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several institutional investors and hedge funds have recently made changes to their positions in GRDN. Stephens Inc. AR acquired a new stake in Guardian Pharmacy Services in the third quarter worth $189,000. Virtu Financial LLC acquired a new position in shares of Guardian Pharmacy Services during the third quarter valued at $279,000. Barclays PLC acquired a new position in shares of Guardian Pharmacy Services during the third quarter valued at $311,000. Point72 DIFC Ltd acquired a new position in shares of Guardian Pharmacy Services during the third quarter valued at $573,000. Finally, Royce & Associates LP acquired a new position in shares of Guardian Pharmacy Services during the third quarter valued at $1,260,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.